182 related articles for article (PubMed ID: 23729626)
1. Biomarkers in the treatment of cancer: opportunities and pitfalls.
Melichar B
Clin Chem Lab Med; 2013 Jul; 51(7):1329-33. PubMed ID: 23729626
[No Abstract] [Full Text] [Related]
2. Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics.
Kirwan A; Utratna M; O'Dwyer ME; Joshi L; Kilcoyne M
Biomed Res Int; 2015; 2015():490531. PubMed ID: 26509158
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic relevance of a novel multiplex immunoassay panel in breast cancer.
Hermann N; Dressen K; Schroeder L; Debald M; Schildberg FA; Walgenbach-Bruenagel G; Hettwer K; Uhlig S; Kuhn W; Hartmann G; Holdenrieder S
Tumour Biol; 2017 Jun; 39(6):1010428317711381. PubMed ID: 28618926
[TBL] [Abstract][Full Text] [Related]
4. [Tumoral markers in liver cirrhosis and hepatocellular carcinoma].
Gómez Rubio M; de Cuenca Morón B; Domínguez M
Gastroenterol Hepatol; 2005 May; 28(5):308. PubMed ID: 15871818
[No Abstract] [Full Text] [Related]
5. [1959-1999: from serum markers to 18-FDG in oncology. The experience of the René-Huguenin Center].
Pecking AP; Mechelany-Corone C; Pichon MF
Pathol Biol (Paris); 2000 Nov; 48(9):819-24. PubMed ID: 11141917
[TBL] [Abstract][Full Text] [Related]
6. Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation.
Reiter MJ; Costello JE; Schwope RB; Lisanti CJ; Osswald MB
J Comput Assist Tomogr; 2015; 39(6):825-34. PubMed ID: 26248153
[TBL] [Abstract][Full Text] [Related]
7. BR-MA, OM-MA, GI-MA and CEA: clinical evaluation using the IMMULITE analyzer.
van Dalen A
Tumour Biol; 1999; 20(3):117-29. PubMed ID: 10213919
[TBL] [Abstract][Full Text] [Related]
8. Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.
Yu M; Wang YH; Abdalla AME; Liu WQ; Mei F; Wang J; Ouyang CX; Li YQ
J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):722-728. PubMed ID: 25318883
[TBL] [Abstract][Full Text] [Related]
9. Tumor marker guidelines.
Sklaroff RB
J Clin Oncol; 1997 May; 15(5):2175-6. PubMed ID: 9164236
[No Abstract] [Full Text] [Related]
10. Serum carcinoembryonic antigen, cancer antigen 125, cancer antigen 15-3, squamous cell carcinoma, and tumor-associated trypsin inhibitor concentrations during healthy pregnancy.
Schlageter MH; Larghero J; Cassinat B; Toubert ME; Borschneck C; Rain JD
Clin Chem; 1998 Sep; 44(9):1995-8. PubMed ID: 9732993
[No Abstract] [Full Text] [Related]
11. [Tumor markers in gynecology].
Alekseeva ML; Fanchenko ND; Novikov EA; Margiani FR
Akush Ginekol (Mosk); 1995; (5):35-7. PubMed ID: 8579206
[No Abstract] [Full Text] [Related]
12. Effect of obesity-related plasma hemodilution on serum tumor marker concentration in women.
Park M; Chang IH; Kang H; Han SS
J Obstet Gynaecol Res; 2015 May; 41(5):784-9. PubMed ID: 25421332
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer.
Pedersen AC; Sørensen PD; Jacobsen EH; Madsen JS; Brandslund I
Clin Chem Lab Med; 2013 Jul; 51(7):1511-9. PubMed ID: 23403727
[TBL] [Abstract][Full Text] [Related]
14. Stability of tumor markers CA 19.9, CA 125, and CA 15.3 in serum obtained from plain tubes and tubes containing thixotropic gel separator.
Banfi G; Parma P; Pontillo M
Clin Chem; 1997 Dec; 43(12):2430-1. PubMed ID: 9439470
[No Abstract] [Full Text] [Related]
15. Tumour markers with clinically controlled cut-offs for suspected cancer.
Bosch X; Molina R; Marrades R; Augé JM; Pellicé M; López-Soto A
Eur J Clin Invest; 2021 Jul; 51(7):e13523. PubMed ID: 33594702
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of tumour markers in endometrial cancer.
Lo SS; Cheng DK; Ng TY; Wong LC; Ngan HY
Tumour Biol; 1997; 18(4):241-9. PubMed ID: 9218009
[TBL] [Abstract][Full Text] [Related]
17. Self-Calibrating On-Chip Localized Surface Plasmon Resonance Sensing for Quantitative and Multiplexed Detection of Cancer Markers in Human Serum.
Yavas O; Aćimović SS; Garcia-Guirado J; Berthelot J; Dobosz P; Sanz V; Quidant R
ACS Sens; 2018 Jul; 3(7):1376-1384. PubMed ID: 29947221
[TBL] [Abstract][Full Text] [Related]
18. Measurement of c-erbB-2 proteins in sera from patients with carcinomas and in breast tumor tissue cytosols: correlation with serum tumor markers and membrane-bound oncoprotein.
Wu JT; Astill ME; Gagon SD; Bryson L
J Clin Lab Anal; 1995; 9(3):151-65. PubMed ID: 7541455
[TBL] [Abstract][Full Text] [Related]
19. Molecular methods for the diagnosis of cancer.
Cairns P; Sidransky D
Biochim Biophys Acta; 1999 Mar; 1423(2):C11-8. PubMed ID: 10214347
[No Abstract] [Full Text] [Related]
20. Interchangeability between control material and patient serum in tumor biomarker assessment.
Dittadi R; Gion M
Int J Biol Markers; 2003; 18(3):230-1. PubMed ID: 14535596
[No Abstract] [Full Text] [Related]
[Next] [New Search]
